25I vs 8EV: Side-by-Side Comparison
Compare IMMUPHARMA PLC LS-01 (25I) and EVGEN PHARMA PLC LS-0025 (8EV) side by side: market cap EUR 14.35M vs EUR 5.29M. Financials, growth and model signals on Bullrun.
| Metric | 25I | 8EV |
|---|---|---|
| Company | IMMUPHARMA PLC LS-01 | EVGEN PHARMA PLC LS-0025 |
| Country / Exchange | United Kingdom · F | United Kingdom · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 14.35M | EUR 5.29M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 0 | EUR 0 |
| Revenue growth YoY | — | -100.0% |
| Net income | EUR -2.48M | EUR -1.94M |
| Gross margin | — | — |
| Diluted EPS | -0.01 | -0.00 |